Join
Live feed
·
PRReleasevia Quantisnow
United Therapeutics Corporation logo

United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension

ByQuantisnow·Wall Street's wire, on your screen.
UTHR· United Therapeutics Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UTHR (United Therapeutics Corporation) and more on Quantisnow.